Perseus Proteomics Inc. announced the sales launch of new antibodies/reagents: Anti-mAQP4 antibody (for reproducing symptoms of neuromyelitis optica in animal experiments, etc.). Anti-DOTA antibody (for measuring DOTA-bound antibodies concentration in blood in animal experiments or clinical trials, etc.). Anti-DM1 antibodyfor measuring ADC concentration in blood in animal experiments or clinical trials, etc.).

The company provided various antibodies/reagents for researchers at academia or companies throughout the world. The company will provide various services to support research activities of academia and companies.